
New Clinical Trial – Modified Citrus Pectin Halts Prostate Cancer Progression
A new double-blind clinical trial on modified citrus pectin (MCP) against biochemically relapsed prostate cancer is opening new doors in the treatment of this aggressive disease. Download the full article (pdf)
Read More